MP

Mike Pellini

I am no longer receiving messages via LinkedIn. Please use email or other. Too many inbound to respond to on a regular basis

Dana Point, California

Investor
VC

Invests in

Stages:

Series B
Series A
Seed

Sectors:

Pharmaceuticals
BioTech
Digital Health
Health & Hospital Services
Health IT

Locations:

California
  • Min Investment:

    $10,000.00
  • Max Investment:

    $50,000.00
  • Target Investment:

    $25,000.00

Education

  • TJ

    Thomas Jefferson University

    (1993 - 1997)

  • DU

    Master of Business Administration - MBA

    Drexel University's LeBow College of Business

  • BC

    Bachelor’s Degree

    Boston College

    (1983 - 1987)

  • DU

    MBA

    Drexel University's LeBow College of Business

Lists including Mike

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Investments

Octave

Series A

Total Funding: $150M

AltPep

Series B

Total Funding: $53M

MedCrypt

Series A

Total Funding: $33M

Nucleai

Series B

Total Funding: $130M

ONI

Series B

Total Funding: $75M

Exai Bio

Series A

Total Funding: $68M

ScienceIO

Seed

Total Funding: $8M

TwinStrand Biosciences

Series B

Total Funding: $50M

Miroculus

Series B

Total Funding: $48M

Vineti

Series B

Total Funding: $100M

Work Experience

Section 32

2017

  • Managing Partner

    2017

    www.section32.com

FM
Foundation Medicine, Inc.

2011 - 2018

  • Chairman

    2017 - 2018

  • CEO

    2011 - 2017

Clarient, Inc.

2007 - 2011

  • President and COO

    2007 - 2011

All information is sourced from public domain and might be inaccurate.

|

By continuing, you're agreeing to our Terms and Privacy Policy.

|

Learn more About The Network.